Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

Managed Services Contract - Medical Biochemistry & Immunology

Cardiff and Vale University Health Board

This public procurement record has 1 release in its history.

AwardUpdate

21 Mar 2025 at 00:00

OJEU - F20 - Modification Notice
Summary of the contracting process

The Cardiff and Vale University Health Board is overseeing a procurement process for a managed services contract in Medical Biochemistry & Immunology. This service pertains to the medical and healthcare industry category and will be provided at Cardiff and Vale University Health Board, located in Cardiff, UK. The contract extension involved in this procurement process includes significant due diligence and planning stages. The process aims to replace key analytical equipment and the Laboratory Information Management System (LIMS) and addresses critical deadlines and milestones due to end-of-life equipment and interoperability requirements. The contract’s modification extends its duration by an additional five years to maintain a high standard of clinical service and to mitigate risks associated with current equipment downtimes potentially affecting patient care.

This tender represents a significant opportunity for businesses specializing in healthcare services, particularly those providing medical equipment and systems integration. Suppliers with expertise in medical biochemistry, immunology, and reliable turnaround times in lab results will find this tender particularly suitable. The potential to engage in a long-term contract valued significantly can offer stable business growth. Large-scale suppliers with the ability to support a high-demand clinical environment, and who can manage the installation and maintenance of complex laboratory equipment, will be well-positioned to compete for this tender. Engaging at this level could further enhance a supplier’s market presence and foster long-term relationships within the NHS infrastructure.

How relevant is this notice?

Notice Information

Notice Title

Managed Services Contract - Medical Biochemistry & Immunology

Notice Description

Lot Information

Lot 1

Tender Process timing - To ensure that the appropriate level of detail and due diligence is applied to any future tender it is has been established that a five-year extension to the current contract would be necessary for the following reasons; - The need to provide a safe sustainable Clinical service during the tender process. The Clinical risk of not having an operational Medical Biochemistry and Immunology service within Cardiff and Vale is significant as the laboratory is involved in 70% of all Clinical decisions - around 90% of the work undertaken within the department requires a 2 hour turnaround from time of receipt to reporting of the result which can only be achieved with an onsite service supported by hardware and the LIMS system. - 12 months to write and refine the tender specification - there is currently no specification written other than the one issued around 2007 - this requires time to ensure all key points are covered - 24-36 Months to go through the tender process including viewing potential options open to us to ensure an informed choice is made. - 12-24 Months Implementation - this would include phasing out the current equipment following validation and verification of any new platforms - some assays may require significant patient rebase lining which means dual running to evaluate any change in results on a personal patient basis - during this period a contract will still be required with Abbott diagnostics. - Tender processes - there is evidence from other sites within the UK including legal precedence that show the above is a realistic timeline. End of life-cycle equipment - The current equipment provided under the managed service contract with Abbott including Alinity analysers and associated automation (sample tracking and movement system) is 8 years old and needs replacing. A five-year contract could achieve this cost effectively, but any lesser period would place huge financial pressures on the HB in duplicative costs and may not be achievable. In the short term, not changing the aging equipment now and attempting to run it for a further 2-3 years to undertake a procurement exercise (notwithstanding the technical/resource limitations) would create a significant patient risk as the analysers down time which is likely to increase, will have a detrimental effect on the department's ability to turnaround the majority of work within the required 2 hours' time window, this places patients at risk by not being able provide laboratory results to make a clinical decision. Accordingly, the indication is that a period of less than five years is not economically viable to replace the current system. - There is also an indication that the automation is nearing its end of life, this is evidenced by the increased down time of individual components on the tracking system and time taken to obtain parts, life expectancy of this equipment is around 8 years although that is not a hard end point as with the LIMS, rather it is an unknown risk that could materialise or escalate in severity over time. Abbott Diagnostics are no longer contracting their track system to Inpeco and going forward would not be able to hold the risk under the MSC due to this contracting change. - As indicated 8 years is the usual life cycle of both analytical and tracking systems, although the equipment is still fully functional down time will increase and for the track will take longer to obtain, this increased downtime will seriously affect our ability to meet the 2 hours' time window for the return clinical results required to treat patients

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-kuma6s-148722
Publication Source
Sell2Wales
Latest Notice
https://www.sell2wales.gov.wales/search/search_switch.aspx?ID=148722
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
OJEU - F20 - Modification Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Not Specified
Procurement Method Details
Not specified
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

71 - Architectural, construction, engineering and inspection services

CPV Codes

71900000 - Laboratory services

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£99,652,745 £10M-£100M

Notice Dates

Publication Date
21 Mar 20251 years ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
30 Dec 200916 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Not Specified
Lots Status
Not Specified
Awards Status
Not Specified
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
Cardiff and Vale University Health Board
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
CARDIFF
Postcode
CF14 4HH
Postcode Area
Cardiff
Country
Wales
Major Region (ITL 1)
TLL Wales
Basic Region (ITL 2)
TLL5 South East Wales
Small Region (ITL 3)
TLL52 Cardiff and Vale of Glamorgan
Delivery Location
TLL22 Cardiff and Vale of Glamorgan
Local Authority
Cardiff
Electoral Ward
Heath
Westminster Constituency
Cardiff North

Supplier Information

Number of Suppliers
1
Supplier Name

ABBOTT LABORATORIES LIMITED

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...